In recent years, Spain has experienced extraordinary growth in the biotechnology sector, consolidating itself as a key area for innovation, research and economic development.
Thanks to the joint efforts of institutions, associations and companies, the Spanish biotech ecosystem has not only matured but has also achieved record figures in terms of investment, business development and social impact.
According to Ion Arocena,general director of AseBio, the sector has reached historic milestonesin recent years: investment in R&D has exceeded 1,200 million euros, and biotech companies have secured nearly 230 million euros in private investment, setting an all-time record. This growth is also reflected in the business landscape, which has expanded from just over 50 biotech companies two decades ago to close to 1,000 today.
Klinea’s role in the transformation of the biotech industry
Amid this growth, at Klinea we have established ourselves as a key player in the industrialization and technological development of the sector. As an engineering company specialized in the design and development of industrial processes, we offer high quality solutions that allow Biotech companies to scale their production in an efficient and sustainable way.
“Biotech companies are investing in industrializing their processes, and this is where Klinea can add value to their capabilities, helping them to transform R&D into innovative industrial solutions” – Ion Arocena
Klinea is an active member of the Spanish Association of Biocompanies – AseBio. AseBio -and this gives us access to a unique platform of connection, strategic insights and opportunities that drive our growth and strengthen our position in the market. These types of collaborations are essential for the biotech ecosystem in Spain, as they foster innovation and development. According to Arocena: “Having Klinea’s experience in engineering and process development is key to the maturity of the Biotech sector in Spain”.
This recognition highlights our role in building a very promising future for Spain’s biotechnology sector. Klinea not only contributes to the strengthening of the industrial infrastructure, but also positions itself as a key driver of the sector’s sustainability.
Our commitment to research and development, combined with our ability to adapt innovative processes to market demands, enables Biotech companies not only to improve their competitiveness, but also to accelerate their time to market with more efficient, high-quality products.
Our alliance with other companies, associations and research centers strengthens the ecosystem, promoting an open collaboration that favors the transfer of knowledge and the implementation of cutting-edge technological solutions. In this way, Klinea is positioned as an essential piece to guarantee the sustained growth and consolidation of the country’s biotechnology sector.
